Video summary

Why Do Some Cancers Cure Themselves?

Main summary

Key takeaways

Science and Nature

Scientific concepts, discoveries, and nature/biomedical phenomena

Body tissue repair vs. cancer

  • Normal injuries and many infections resolve through the body’s repair and clearance systems.
  • Cancer is typically not self-curing:
    • Without treatment, it can grow and metastasize.
    • This progression can eventually lead to death.

Spontaneous remission

  • A rare phenomenon in which tumors shrink or disappear without direct cancer treatment.
  • Estimated rarity (as cited): about 1 in 60,000 cancer patients.
  • When remission occurs, it can be temporary:
    • Relapse may happen within months or years.

Historical evidence for spontaneous remission

  • Ebers papyrus (c. 1550 BCE): earliest mention of cancer “vanishing.”
  • Peregrine Laziosi (13th century, Italian priest):
    • Reported disappearance of a leg tumor before amputation.
    • Later became a symbolic “patron saint” figure for cancer patients.
  • Arsène-Hippolyte Vautier (1813):
    • Reports that tumors in cancer patients with gangrene sometimes shrank.
  • Additional 19th–20th century physician reports describe recoveries following other illnesses.

Trends in which cancers remit

Some cancers appear more prone to spontaneous remission, including:

  • Neuroblastoma (pediatric nerve cancer; mostly under age 5)
  • Kidney cancer
  • Metastatic skin cancer
  • Leukemia

Limitations in documentation are emphasized. Example:

  • Late-stage skin cancer had only 76 well-documented cases as of 2013,
    • spanning reports from 1866 onward.

Infection/immune response hypotheses

  • Observation: some people with spontaneous remission have also experienced infections (viral or bacterial).
  • Example cited: 14 cases of spontaneous remission linked to COVID-19 (2023).
  • Proposed mechanism: immune system activation
    • Cancer treatments can release tumor antigens.
    • Immune cells recognize tumor antigens and attack cancer cells.

Caution: Intentionally seeking infection (e.g., COVID) is unsafe because cancer patients can have a higher mortality risk from COVID.

Vaccination anecdotes (supportive, not proof)

Presented as repeated observations suggesting an immune/antigen linkage (but not establishing causality):

  • Smallpox vaccine (1978):
    • A leukemia patient reportedly entered total remission.
  • Tdap vaccine (more recent case):
    • A skin cancer patient reportedly recovered after vaccination.

Non-infection triggers

Spontaneous remission can occur after:

  • Biopsies or routine screening

Hypothesis:

  • These procedures may disrupt tumor blood supply—described metaphorically as starving tumors of blood, since tumors “need a lot of blood.”

Microbial therapy / bacterial mechanisms (historical therapeutic approach)

  • Coley’s Toxin (William Coley, 1890):
    • Injection of inactivated bacteria for inoperable skin and bone cancers.
    • Reported outcomes (as cited):
      • ~52% remission for five years
      • ~20% alive after 20 years
    • Used until 1963, then declined due to skepticism and unknown mechanism.

Modern virotherapy concept

  • T-VEC:
    • FDA-approved therapy using a modified virus intended to destroy cancer cells.
    • The subtitles note uncertainty:
      • The company indicates they don’t fully know how the virus produces the effect.

Listed methodology / line of reasoning (as presented)

  • Evidence accumulation
    • Compile historical and modern case reports of tumor shrinkage without treatment
    • Track rarity and variability across cancer types
  • Identify possible triggers
    • Infections (viral/bacterial exposure)
    • Vaccination events (as analogous immune stimulation)
    • Medical procedures (biopsy/screening) that may alter tumor access to blood
  • Generate hypotheses
    • Immune recognition of tumor antigens
    • Reduced tumor vascular supply after procedures
    • Possible genetic/biological factors (mentioned as potential, but not treated as settled)

Researchers / sources featured (as named in subtitles)

  • Harry Plumley (SciShow Patreon supporter)
  • Charlie Stanley (SciShow Patreon supporter)
  • TJ Steyn (SciShow Patreon supporter)
  • Imhotep / Imhotepno (Egyptian physician name as stated in subtitles; associated with early incision/infection idea)
  • William Coley
  • Peregrine Laziosi
  • Arsène-Hippolyte Vautier
  • FDA (regulatory body referenced regarding T-VEC approval)
  • SciShow (channel/source; referenced as production context, not a single researcher)

Note: Some other items (e.g., “a study from Denmark,” “doctors reported 14 cases,” and “another more recent case”) are mentioned without naming specific investigators or journals in the provided subtitles.

Rate this summary

Your feedback will help improve summaries.

Improve this summary

Reprocess with a stronger model when the summary feels incomplete or inaccurate.

Pro

Translate summary in another language

Pro

Ask questions to this video

Chat for follow-up questions, clarifications, and source-backed answers.

Coming soon

Share this summary

Original video